Skip to content

Medpace Voice

Tag: Phase I Unit

Clinical Development

Redefining Cardiovascular Safety Through an Integrated Approach: The Increased Utilization of Concentration-QTc Analysis

  • January 27, 2026

Successfully executing a C-QTc analysis requires the seamless integration of specialized clinical operations, technical ECG expertise, advanced biometrics, and focused reporting. Learn more.

Clinical Development

Bridging Early-Phase Insight to Late Phase Success | Inside Medpace’s New Phase I Unit Facility 

  • August 28, 2025

With the launch of a newly built, state-of-the-art clinical pharmacology unit, Medpace strengthens its position as a strategic early phase...